Categories: Technology

BionIT Labs Launches Adams Hand for Humanoids and Service Robots

Image by BionIT Labs

SOLETO, Italy, Jan. 19, 2026 (GLOBE NEWSWIRE) — BionIT Labs, a pioneer in human-machine interfaces, today announced that Adam’s Hand for Physical AI systems is now available for integration with robotics platforms, closing a long-standing gap between artificial intelligence and the physical world. The announcement follows a debut at CES 2026, where Adam’s Hand demonstrated advanced dexterity on two humanoid robots.

While BionIT Labs’ roots are in advanced prosthetics, the company has evolved Adam’s Hand from assistive medical devices to AI-native robotic dexterity infrastructure. The platform delivers what Physical AI has been missing: high-fidelity, real-world manipulation data paired with proven, human-scale hardware.

“AI can reason, plan, and predict, but without dexterity, it cannot act,” said Giovanni Zappatore, Founder and CEO of BionIT Labs. “Dexterity is the missing link. Without embodied intelligence, Physical AI cannot scale. Adam’s Hand is designed from the ground up to bring AI into contact with the real world.”

BionIT Labs supports robotics manufacturers, research groups, and system integrators as an integration partner, focusing on applied testing and performance validation in real operating conditions.

At CES 2026, Adam’s Hand was showcased on:

  • Robee R, an industrial humanoid developed with STMicroelectronics, demonstrating robust functional grip and operational reliability in real-world scenarios.
  • Robee M, a medical humanoid featured at the Intel booth, demonstrating safe and natural human-robot interaction.

Watch Adam’s Hand in action as it interacts naturally with the world: https://www.youtube.com/shorts/kM4Zt-3iba8  

“Prosthetics and robotics share the same non-negotiable constraints,” added Zappatore. “You need dexterity you can rely on, sensing that remains stable over time, maintenance aligned with real-world operation, and hardware engineered for continuous use. Embodied intelligence exposes these constraints immediately, and our technology has been built where failure is not an option.”

All robotics work at BionIT Labs follows the same safety, ethics, and compliance standards established in medical-device development, including human-centered design and responsible handling of human-related data.

Adam’s Hand for Physical AI systems is available now for robotics integration projects, including proof-of-concept deployments and collaborative development programs.

For more information, visit https://bionitlabs.com/robotics/

About BionIT Labs

BionIT Labs already established in the prosthetic field, develops advanced human-machine interfaces and robotics solutions. Its flagship product, Adam’s Hand, brings real-world dexterity to humanoid and service robots.

Media Contact:
Cristina Longo
Marketing & Communication Manager
+39 3933800324
c.longo@bionitlabs.com
https://bionitlabs.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1f0dec5f-31dc-4892-a273-8b9203d8cb2e

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2428bfa4-cc98-471e-b5f2-a06c693a3a14

GlobeNews Wire

Recent Posts

NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 23, 2026…

4 hours ago

Cambrex Advances US and European Expansions

EAST RUTHERFORD, N.J., March 23, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and…

4 hours ago

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on…

11 hours ago

Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna…

11 hours ago

Laigo Bio completes final close of oversubscribed seed financing of 17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

Additional funding of €4m from new co-lead investor Biovance Capital, and €1.5m from existing co-lead…

11 hours ago

Mayson Raises Pre-Seed Funding for Its Full-stack Vibe Coding Platform

The platform enables builders to turn a single prompt into production-grade software, with scalable backend…

11 hours ago